Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
77,331,078
-
Total 13F shares
-
5,377,405
-
Share change
-
-332,431
-
Total reported value
-
$32,047,000
-
Price per share
-
$5.90
-
Number of holders
-
20
-
Value change
-
-$2,511,469
-
Number of buys
-
4
-
Number of sells
-
10
Institutional Holders of Xenon Pharmaceuticals Inc. - Common Stock (XENE) as of Q2 2016
As of 30 Jun 2016,
Xenon Pharmaceuticals Inc. - Common Stock (XENE) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,377,405 shares.
The largest 10 holders included
BVF INC/IL, Capital World Investors, Invesco Private Capital, Inc., PERCEPTIVE ADVISORS LLC, Opaleye Management Inc., ROYAL BANK OF CANADA, Point72 Asset Management, L.P., DAFNA Capital Management LLC, Novo A/S, and State of New Jersey Common Pension Fund D.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.